Hallux Announces Poster Exhibit Abstract ID 74740 on Dermatophytoma Treatment by HSG 42 in Phase 2a trial Available for ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...
TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, announced today that a video poster abstract presentation on the efficacy and safety ...
All ESA Annual Meeting proposal and abstract deadlines are 5:00 PM Eastern so that technical support and ESA staff assistance will be immediately available when submitters need it. If you begin your ...
BioLineRx Ltd. (NASDAQ:BLRX) reported second quarter 2025 results, producing license revenues of $304,000. Following the transition of commercialization responsibilities of Aphexda (motixafortide) to ...
Successful abstracts exhibit what is generally accepted as good scientific communication. The following guidelines specify all aspects of how a good abstract is written. Title The Title is informative ...
Laurel Hitchcock, PhD., Allison Shorten, PhD., Peter Bosworth, MBA., Shawn Galin, PhD, Tara Edmonds, PhD., Caroline Harada, MD., Using a Standardized Patient Model ...
With the fall ACS national meeting right around the corner, the time has come to put your poster presentation together. While the abstract was submitted months ago, you were waiting to create the ...
Please Note: The submission website supports the latest version of Chrome, the current and previous release of Firefox, Safari and Microsoft browsers. Cookies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results